To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
26 Current white paper about the topic proteinsrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
Reliable exclusion of sample carry-over and cross-contamination during pipetting of blood and plasma with positive displacement pipettes
Blood and plasma contain proteins that can lead to foaming during pipetting. This makes it difficult to pipette accurately and without contamination
A major concern in recombinant biologics is rapid clearance from blood stream. The attachment of polymers can be an approach to overcome this limitation
Read how GPCRs are studied at endogenous expression levels by employing CRISPR/Cas9.
CRISPR/Cas9 genome-edited cells express nanoBRET-donor that monitors protein interaction and trafficking
N-glycans, reduced glycitols, glycosyl-amines, 1-amino-glycitols, glycomics
The invention presented here provides an improved method for the preparation of multiple types of glycans and their usage
The BIOSTAT® Qplus with up to 12 culture vessels represents the basis for a professional and time-saving process optimization.
Design of experiments (DoE) is one of the most important techniques for systematic planning, execution and statistical evaluation of experiments. Although a DoE investigation is executable in one bioreactor, multi-bioreactor systems designed for pa
Each antibody-antigen interaction has unique characteristics. A protocol giving good results for one antibody-antigen pair might found to be unsatisfactory for a second antibody even on the same sample. The interaction of antisera with protein epitop
Smart Solutions for large Molecules
As demonstrated here, there are a broad range of HPLC applications used in development, production, validation and release of protein therapeutics for human use. Some of the applications mentioned above are mandatory when submitting a new biopharmace